CAPECITABINE, CAPECITABINE, CARBOPLATIN, Datopotamab deruxtecan, ERIBULIN MESYLATE, PACLITAXEL ALBUMIN-BOUND, PACLITAXEL
D926PC00001
Phase 3 small_molecule active
Quick answer
CAPECITABINE, CAPECITABINE, CARBOPLATIN, Datopotamab deruxtecan, ERIBULIN MESYLATE, PACLITAXEL ALBUMIN-BOUND, PACLITAXEL for Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active